We performed IHC on ninety pairs of tissue samples from HCC patients, including 79 HBV-HCC and 11 non-HBV-HCC patients with antibodies against CFL1 and ADFP, respectively. This evidence concerns the gene PLIN2 and hepatocellular carcinoma.